HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$5.40
Day range
$4.15 - $5.22
Year range
$2.79 - $11.98
Market cap
49.50M USD
Avg Volume
113.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.18M | 47.00% |
Net income | -4.51M | -42.52% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.18M | -47.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.05M | -37.56% |
Total assets | 30.29M | -36.59% |
Total liabilities | 3.70M | 56.58% |
Total equity | 26.60M | — |
Shares outstanding | 10.78M | — |
Price to book | 2.19 | — |
Return on assets | -39.31% | — |
Return on capital | -44.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.51M | -42.52% |
Cash from operations | -5.58M | -54.54% |
Cash from investing | 680.34K | 193.60% |
Cash from financing | 11.99K | — |
Net change in cash | -4.87M | -43.66% |
Free cash flow | -3.88M | -77.55% |
About
Founded
2013
Headquarters
Website
Employees
21
